Transgene Biotek share news, announcements and annual reports
BSE: 526139Healthcare ServicesSmall Cap
Transgene Biotek Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1993
Last close ₹2.45up ₹0.12 (5.15%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹2.33.
2 Nov: open ₹2.38, high ₹2.57, low ₹2.29
52-week range of traded prices to 2 Nov 2026
₹1.83Low, 4 Feb 2026₹4.19High, 11 Nov 2025
- Under BSE's graded surveillance, stage 0, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹19 Cr4,238th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.22
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.05
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 21,872
Transgene Biotek board meetings
112 filed, newest first. Page 3 of 3.
Mar 2018
21 Mar · Board meeting
Sep 2016
2 Sep · Board meeting
Apr 2015
17 Apr · Board meeting
Board of Directors of the Company at its meeting held on April 17, 2015, following decision has been taken: - Smt L Sujana is appointed ....
Dec 2014
8 Dec · Board meeting
Board of Directors of the Company at its meeting held on December 06, 2014, inter alia, taken the following decisions : 1. S/Sri Sarang ....
Oct 2013
Aug 2013
16 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 15, 2013, inter alia, has decided to convert interest free unsecured loans ....
Sep 2012
4 Sep · Board meeting
Board of Directors of the Company at its meeting held on September 03, 2012, inter alia, has decided to delist the equity shares of the Company ....
Oct 2011
4 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 03, 2011, has allotted 2,500,000 GDRs underlying 25,000,000 Equity Shares ....
Sep 2011
30 Sep · Board meeting
At the meeting of the Board of Directors of the Company held on September 30, 2011, it was decided to open the Issue of GDRs upto USD 20 million ....
Feb 2011
23 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 22, 2011, the Company has allotted 2,500,000 GDRs underlying 25,000,000 ....18 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 18, 2011, has decided to open the issue of GDRs upto USD 40 million on February ....
Oct 2010
1 Oct · Board meeting
Board of Directors of the Company at its meeting held on September 30, 2010, has taken the following decisions: 1. To raise funds for ....